
Articles
-
1 week ago |
benefitsandpensionsmonitor.com | Josh Welsh
Semaglutide, the ingredient in Ozempic and Wegovy, will soon move to generic status in Canada and consultants hope this sparks plan sponsors to take a proactive approach to weight management By Jun 20, 2025 Novo Nordisk’s unexpected loss of Canadian patent protection for semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, has left many in the group benefits space asking hard questions.
-
1 week ago |
benefitsandpensionsmonitor.com | Josh Welsh
Fund reaffirms sustainable investing focus because they are "at the heart" of its fiduciary responsibility By Jun 19, 2025 One of Canada’s largest pension funds and a member of the Maple 8 has introduced a new climate strategy for 2025–2030, reinforcing its long-term commitment to building a climate-resilient portfolio and supporting the real economy’s transition.
-
1 week ago |
benefitsandpensionsmonitor.com | Josh Welsh
Survey finds environmental conditions are affecting eye health, but what can plan sponsors do to mitigate the risks? By Jun 19, 2025 Despite nearly universal recognition of eye health as a key component of wellbeing and a productive workforce, most Canadians are in the dark about how to protect their vision, particularly from the growing risks of environmental exposure.
-
1 week ago |
benefitsandpensionsmonitor.com | Josh Welsh
ADHD experts from Nüense and Biron Health break down stereotypes for plan sponsors By Jun 19, 2025 Employers are constantly faced with daily challenges and chief among them, catering to the individual needs of their workforce. Notably, for those with plan members who are diagnosed with ADHD, that often means navigating invisible hurdles.
-
1 week ago |
benefitsandpensionsmonitor.com | Josh Welsh
VP at HOOPP outlines what’s causing a decline of pension coverage in the workplace, ultimately increasing retirement uncertainty By Jun 18, 2025 Recent findings from the Healthcare of Ontario Pension Plan (HOOPP) and Abacus Data’s 2025 Canadian Retirement Survey confirms that uncertainty remains the buzzword.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →